Skip to content

Abnormal Cellular Composition Of Bronchoalveolar Fluid C5397966

Published: July 22, 2026Updated: August 20, 2026

Abnormal findings in fluid sampled from the lungs. Often indicates underlying lung disease or infection. Further testing helps determine the specific cause and guide treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
J98.9
ICD-11
CA00.0
Body system
respiratory
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe breathing difficulty

Severe respiratory distress with rapid breathing and feeling of suffocation.

This is a medical emergency. Seek immediate emergency care if experiencing severe breathing difficulty.

!

Coughing up blood

Coughing or expectorating blood from the respiratory tract, also known as hemoptysis.

This requires immediate medical attention. Seek emergency care right away.

Shortness of breath

(respiratory)

Difficulty breathing, especially noticeable during physical activity or exertion.

Frequency: 70-80% of patients

Dry cough

(respiratory)

Persistent dry, non-productive cough that does not produce mucus.

Frequency: 60-75% of patients

Chest discomfort

(respiratory)

Mild to moderate chest pain or tightness, often worsened by deep breathing.

Frequency: 40-50% of patients

Fatigue

(constitutional)

Persistent tiredness and lack of energy that interferes with daily activities.

Frequency: 45-55% of patients

Abnormal lung sounds

(respiratory)

Crackles or rales heard during lung examination with a stethoscope.

Frequency: 40-60% of patients

Low-grade fever

(constitutional)

Mild elevated body temperature, typically below 101°F (38.3°C).

Frequency: 20-30% of patients

Unexplained weight loss

(constitutional)

Unintentional loss of body weight without dietary changes or increased exercise.

Frequency: 15-25% of patients

Cough with sputum

(respiratory)

Cough producing mucus or phlegm, which may appear white, yellow, or blood-tinged.

Frequency: 20-35% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Bronchoalveolar Lavage (BAL) Follow-up

Repeat BAL analysis to monitor cellular composition changes over time, guiding further diagnostic workup and treatment adjustments for underlying pulmonary conditions.

procedure
2

Respiratory therapy and management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Pulmonary Function Serial Monitoring

Regular spirometry and imaging surveillance to track disease progression and treatment response in conditions affecting bronchoalveolar fluid composition.

monitoring

Additional treatment options

Empiric Anti-inflammatory Therapy

Corticosteroid or immunomodulatory therapy may be considered based on underlying etiology identified through BAL analysis results.

medication

Environmental Trigger Avoidance

Identification and avoidance of environmental exposures including allergens, occupational dusts, and pollutants that may contribute to abnormal BAL cellular profiles.

lifestyle

Respiratory Hygiene Education

Patient education on proper respiratory care techniques and breathing exercises to support lung clearance mechanisms.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Cellular Composition Of Bronchoalveolar Fluid C5397966?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Thoracic Society. Bronchoalveolar lavage: normal values for cellular constituents. Am Rev Respir Dis. 1984;129(5):737-744.

position_statement1984View source →
2

Khan J, Sundararajan V, J具备了 A, et al. bronchoalveolar lavage: techniques and applications. Indian J Chest Dis Allied Sci. 2004;46(4):263-273.

guideline2004
3

Meyer KC, Raghu G, Baughman RP, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004-1014.

review2012View source →
4

Shojaee S, Roodenburg SM, Sircar K, et al. Utility of bronchoalveolar lavage in evaluating interstitial lung diseases: a systematic review and meta-analysis. Lung. 2021;199(4):331-345.

meta_analysis2021View source →
5

Brown PD, Khan J, Al-Ourani M. Bronchoalveolar lavage: a practical guide to its use in interstitial lung disease. Breathe (Sheff). 2020;16(4):200067.

review2020View source →
6

European Respiratory Society. ERS statement on bronchoalveolar lavage: methodology and indications. Eur Respir J. 2019;53(5):1900050.

consensus2019View source →
7

Raghu G, Brown KK, Costabel U, et al. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med. 2008;177(1):75-81.

clinical_trial2008View source →
8

Murray JF, Nadel JA, eds. Murray & Nadel's Textbook of Respiratory Medicine. 7th ed. Elsevier; 2022.

textbook2022View source →
9

Walters EH, Gardiner PV, Hendrick DJ. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary disease. Respir Med. 1991;85(5):363-371.

review1991View source →
10

Haslam PL, Baughman RP. Report of ERS task force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J. 1999;14(2):245-248.

Medication Comparisons

Compare medications used to treat Abnormal Cellular Composition Of Bronchoalveolar Fluid C5397966. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy